Erratum: Metabolite Profiling of Bendamustine in Urine of Cancer Patients after Administration of [14C]Bendamustine (Drug Metabolism and Disposition (2012) 40 (1297-1307) DOI: 10.1124/dmd.112.045229);Metabolite profiling of bendamustine in urine of cancer patients after administration of [14C]bendamustine

Drug Metabolism and Disposition

Volumn 40, Issue 7, 2012, Pages 1297-1307

  Dubbelman, Anne Charlotte ^a,b   Jansen, Robert S ^b   Rosing, Hilde ^b   Darwish, Mona ^c   Hellriegel, Edward ^c   Robertson, Philmore ^c   Schellens, Jan H M ^a,d   Beijnen, Jos H ^b,d  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c TEVA PHARMACEUTICALS   (Israel)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA HYDROXYBENDAMUSTINE; BENDAMUSTINE; BENDAMUSTINE C 14; BUTYRIC ACID DERIVATIVE; CHLORMETHINE; CREATININE; CYSTEINE; DRUG METABOLITE; PHOSPHATE; THIOL DERIVATIVE; UNCLASSIFIED DRUG; URIC ACID;

ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DEALKYLATION; DEMETHYLATION; DRUG CONJUGATION; DRUG EXCRETION; DRUG HYDROLYSIS; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG OXIDATION; DRUG STRUCTURE; DRUG TRANSFORMATION; DRUG URINE LEVEL; HUMAN; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; RADIATION DETECTION; TANDEM MASS SPECTROMETRY; URINALYSIS; URINARY EXCRETION;

EID: 84862644226     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.112.045229err     Document Type: Erratum

References (13)

1. Bianco G, Abate S, Labella C, and Cataldi TR (2009) Identification and fragmentation pathways of caffeine metabolites in urine samples via liquid chromatography with positive electrospray ionization coupled to a hybrid quadrupole linear ion trap (LTQ) and Fourier transform ion cyclotron resonance mass spectrometry and tandem mass spectrometry. Rapid Commun Mass Spectrom 23:1065-1074.
2. 14C]bendamustine in rat urine and bile: preliminary structural identification of metabolites. Drug Metab Dispos 35:1744-1753.
3. 14C]bendamustine in patients with relapsed or refractory malignancy. Blood 118:Abstract 2476.
4. Dubbelman AC, Tibben M, Rosing H, Gebretensae A, Nan L, Gorman SH, Robertson P Jr, Schellens JH, and Beijnen JH (2012) Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine. J Chromatogr B Analyt Technol Biomed Life Sci 893-894:92-100.
5. Leoni LM, Bailey B, Reifert J, Bendall HH, Zeller RW, Corbeil J, Elliott G, and Niemeyer CC (2008) Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents. Clin Cancer Res 14:309-317.
6. Levsen K, Schiebel HM, Behnke B, Dötzer R, Dreher W, Elend M, and Thiele H (2005) Structure elucidation of phase II metabolites by tandem mass spectrometry: an overview. J Chromatogr A 1067:55-72.
7. Millington DS, Bohan TP, Roe CR, Yergey AL, and Liberato DJ (1985) Valproylcarnitine: a novel drug metabolite identified by fast atom bombardment and thermospray liquid chromatography- mass spectrometry. Clin Chim Acta 145:69-76.
8. Minkler PE, Ingalls ST, and Hoppel CL (2005) Strategy for the isolation, derivatization, chromatographic separation, and detection of carnitine and acylcarnitines. Anal Chem 77: 1448-1457.
9. Olsen J, Li C, Bjørnsdottir I, Sidenius U, Hansen SH, and Benet LZ (2005) In vitro and in vivo studies on acyl-coenzyme A-dependent bioactivation of zomepirac in rats. Chem Res Toxicol 18:1729-1736.
10. Strijbis K, Vaz FM, and Distel B (2010) Enzymology of the carnitine biosynthesis pathway. IUBMB Life 62:357-362.
11. Teichert J, Baumann F, Chao Q, Franklin C, Bailey B, Hennig L, Caca K, Schoppmeyer K, Patzak U, and Preiss R (2007) Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride. Cancer Chemother Pharmacol 59:759-770.
12. Teichert J, Sohr R, Baumann F, Hennig L, Merkle K, Caca K, and Preiss R (2005) Synthesis and characterization of some new phase II metabolites of the alkylator bendamustine and their identification in human bile, urine, and plasma from patients with cholangiocarcinoma. Drug Metab Dispos 33:984-992.
13. Teichert J, Sohr R, Hennig L, Baumann F, Schoppmeyer K, Patzak U, and Preiss R (2009) Identification and quantitation of the N-acetyl-L-cysteine S-conjugates of bendamustine and its sulfoxides in human bile after administration of bendamustine hydrochloride. Drug Metab Dispos 37:292-301.